AR107856A2 - Método para preparar una composición; composición; dispositivo médico y stent - Google Patents

Método para preparar una composición; composición; dispositivo médico y stent

Info

Publication number
AR107856A2
AR107856A2 ARP170100608A ARP170100608A AR107856A2 AR 107856 A2 AR107856 A2 AR 107856A2 AR P170100608 A ARP170100608 A AR P170100608A AR P170100608 A ARP170100608 A AR P170100608A AR 107856 A2 AR107856 A2 AR 107856A2
Authority
AR
Argentina
Prior art keywords
polymers
polymer
composition
methacrylate unit
room temperature
Prior art date
Application number
ARP170100608A
Other languages
English (en)
Inventor
Hauenstein Dale Dr
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR107856A2 publication Critical patent/AR107856A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C08G77/442—Block-or graft-polymers containing polysiloxane sequences containing vinyl polymer sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/10—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04—Polysiloxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/10—Block- or graft-copolymers containing polysiloxane sequences
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/10—Block or graft copolymers containing polysiloxane sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/045—Polysiloxanes containing less than 25 silicon atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/06—Preparatory processes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/14—Polysiloxanes containing silicon bound to oxygen-containing groups
    • C08G77/16—Polysiloxanes containing silicon bound to oxygen-containing groups to hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/14—Polysiloxanes containing silicon bound to oxygen-containing groups
    • C08G77/18—Polysiloxanes containing silicon bound to oxygen-containing groups to alkoxy or aryloxy groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Silicon Polymers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Métodos para hacer polímeros que curan a temperatura ambiente. Los reactivos incluyen polímeros terminados en siloxano y silanoles. Los reactivos se mezclan, y se deja suceder la polimerización al aire a temperatura ambiente. Los polímeros aceptan los uno o más compuestos terapéuticos. Por lo tanto, se pueden recubrir dispositivos médicos desde los cuales es deseable una liberación controlada de la droga (para administración ya sea local o sistémica) con polímeros de la presente que contienen el compuesto terapéutico. En una forma de realización preferida, se hace reaccionar con polidimetilsiloxano un polímero de poli(MPCʷ : LAMˣ : HPMAʸ : TSMAᶻ) donde w, x, y, y z representan las proporciones molares de los monómeros que se utilizan en la materia prima para preparar el polímero; donde MPC representa la unidad 2-metacriloiloxietilfosforilcolina, LMA representa la unidad metacrilato de laurilo, HPMA representa la unidad metacrilato de 2-hidroxipropilo, y TSMA representa la unidad metacrilato de 3-trimetoxisililpropilo. En otra forma de realización preferida, se incorpora al polímero un compuesto terapéutico, como por ejemplo dexametasona.
ARP170100608A 2005-12-21 2017-03-10 Método para preparar una composición; composición; dispositivo médico y stent AR107856A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/314,372 US7906134B2 (en) 2005-12-21 2005-12-21 Room temperature-curable polymers

Publications (1)

Publication Number Publication Date
AR107856A2 true AR107856A2 (es) 2018-06-13

Family

ID=38173828

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP060105719A AR058862A1 (es) 2005-12-21 2006-12-21 Polimeros que curan a temperatura ambiente
ARP170100608A AR107856A2 (es) 2005-12-21 2017-03-10 Método para preparar una composición; composición; dispositivo médico y stent

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP060105719A AR058862A1 (es) 2005-12-21 2006-12-21 Polimeros que curan a temperatura ambiente

Country Status (6)

Country Link
US (2) US7906134B2 (es)
EP (2) EP1968486B1 (es)
JP (1) JP5264501B2 (es)
AR (2) AR058862A1 (es)
TW (1) TWI402313B (es)
WO (1) WO2007076288A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198867A1 (en) * 1997-09-25 2006-09-07 Abbott Laboratories, Inc. Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy
US8257726B2 (en) 1997-09-26 2012-09-04 Abbott Laboratories Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices
US8057816B2 (en) * 1997-09-26 2011-11-15 Abbott Laboratories Compositions and methods of administering paclitaxel with other drugs using medical devices
US20090216317A1 (en) * 2005-03-23 2009-08-27 Cromack Keith R Delivery of Highly Lipophilic Agents Via Medical Devices
US20100166700A1 (en) 2006-02-28 2010-07-01 Oligasis Corporation Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation
US7673379B1 (en) 2007-05-11 2010-03-09 Abbott Cardiovascular Systems Inc. Method of producing a stent-balloon assembly
ES2566753T3 (es) * 2008-03-31 2016-04-15 Shiseido Company, Ltd. Polisiloxano, compuesto acrílico y compuesto vinílico
WO2009158461A1 (en) * 2008-06-25 2009-12-30 Boston Scientific Scimed, Inc. Medical copolymers
US9416210B2 (en) * 2008-12-12 2016-08-16 The University Of Massachusetts Zwitterionic polymers with therapeutic moieties
JP2012530052A (ja) * 2009-06-15 2012-11-29 ディーエスエム アイピー アセッツ ビー．ブイ． ホスロリルコリンをベースにする医療用両親媒性シリコーン
US8765432B2 (en) 2009-12-18 2014-07-01 Oligasis, Llc Targeted drug phosphorylcholine polymer conjugates
AU2013234955A1 (en) 2012-03-23 2014-11-13 Dennis Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
CN107253545A (zh) * 2012-04-13 2017-10-17 皮博士研究所有限责任公司 模块化填充设备和方法
US10702608B2 (en) 2013-09-08 2020-07-07 Kodiak Sciences Inc. Factor VIII zwitterionic polymer conjugates
US10087526B2 (en) * 2013-12-20 2018-10-02 Microvention, Inc. Stents, packaging, and substances used with stents
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
WO2016061562A2 (en) 2014-10-17 2016-04-21 Kodiak Sciences Inc. Butyrylcholinesterase zwitterionic polymer conjugates
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
RU2744860C2 (ru) 2015-12-30 2021-03-16 Кодиак Сайенсиз Инк. Антитела и их конъюгаты
DE102016107760B4 (de) * 2016-04-26 2018-09-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Essbare Funktionsschichten und Überzüge auf Hybridpolymerbasis für Pharmazie und Lebensmittel
EP3275909A1 (en) * 2016-07-27 2018-01-31 Clariant Plastics & Coatings Ltd Novel polyacrylate-polysilane block copolymers
BE1025004B1 (nl) 2017-02-24 2018-09-24 Oystershell Nv Afpelbare nagellak
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
CN111087686B (zh) * 2019-12-17 2021-09-17 金发科技股份有限公司 一种聚丙烯组合物及其制备方法和应用
CN111286033B (zh) * 2020-02-11 2022-02-18 合肥盖特环保技术有限责任公司 一种接枝聚硅烷类闪烁体及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870766A (en) * 1971-06-18 1975-03-11 Stauffer Chemical Co Method of curing organic polymers and copolymers
WO1986007541A1 (en) * 1985-06-19 1986-12-31 Yasushi Zyo Composition which can impart antithrombotic ability and medical apparatus to be in contact with blood
JPS6296562A (ja) * 1985-10-24 1987-05-06 Shin Etsu Chem Co Ltd シリコ−ン組成物
US5126400A (en) * 1990-07-30 1992-06-30 Dow Corning Corporation Reinforced polyorganosiloxane elastomers
JP3030086B2 (ja) 1991-07-05 2000-04-10 バイオコンパテイブルズ・リミテツド ポリマーの表面コーティング
US6090901A (en) 1991-07-05 2000-07-18 Biocompatibles Limited Polymeric surface coatings
US5705583A (en) 1991-07-05 1998-01-06 Biocompatibles Limited Polymeric surface coatings
US6284854B1 (en) 1991-07-05 2001-09-04 Biccompatibles Limited Polymeric surface coatings
AU682667B2 (en) 1992-12-23 1997-10-16 Tremco, Inc. Alkoxysilane functionalized acrylic polymer composition
US6015815A (en) 1997-09-26 2000-01-18 Abbott Laboratories Tetrazole-containing rapamycin analogs with shortened half-lives
US6890546B2 (en) 1998-09-24 2005-05-10 Abbott Laboratories Medical devices containing rapamycin analogs
US5969075A (en) 1998-07-13 1999-10-19 Shin-Etsu Silicones Of America Process for the production of room temperature curable organopolysiloxane compositions
US6534600B2 (en) * 2001-03-26 2003-03-18 Michigan Molecular Institute Hyperbranched polyureas, polyurethanes, polyamidoamines, polyamides and polyesters
US6918869B2 (en) * 2002-12-02 2005-07-19 Scimed Life Systems System for administering a combination of therapies to a body lumen
TW200538433A (en) * 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
US20050208093A1 (en) 2004-03-22 2005-09-22 Thierry Glauser Phosphoryl choline coating compositions

Also Published As

Publication number Publication date
WO2007076288A3 (en) 2007-12-06
US7906134B2 (en) 2011-03-15
EP2537879A1 (en) 2012-12-26
US8475822B2 (en) 2013-07-02
EP1968486A4 (en) 2010-03-03
TWI402313B (zh) 2013-07-21
WO2007076288A2 (en) 2007-07-05
US20110123702A1 (en) 2011-05-26
EP1968486A2 (en) 2008-09-17
US20070141104A1 (en) 2007-06-21
EP1968486B1 (en) 2014-11-19
JP5264501B2 (ja) 2013-08-14
AR058862A1 (es) 2008-02-27
TW200736340A (en) 2007-10-01
JP2009521489A (ja) 2009-06-04
EP2537879B1 (en) 2015-01-21

Similar Documents

Publication Publication Date Title
AR107856A2 (es) Método para preparar una composición; composición; dispositivo médico y stent
ES2753601T3 (es) Materiales dentales que utilizan polímeros termoendurecibles
CY1124517T1 (el) Επικαλυψεις απελευθερωσης φαρμακευτικης ουσιας για ιατρικες διαταξεις
US20190070826A1 (en) Hydrogel-elastomer hybrids
US9399123B2 (en) Silicone adhesive compositions
BR112015014969A2 (pt) micromatriz para entrega de agente terapêutico e métodos de uso
CY1110813T1 (el) Χημικες ενωσεις
PE20060973A1 (es) Administracion transdermica de drogas basada en el tamano de los cristales
WO2007092894A3 (en) Drug delivery system and method of manufacturing thereof
ATE432955T1 (de) Polyglutamat-aminosäure-konjugate und verfahren
CR20110515A (es) Compuesto biocompatible y su uso
WO2007121065A3 (en) Durable biocompatible controlled drug release polymeric coatings for medical devices
BRPI0410377A (pt) implantes medicinais revestidos bio-compatìveis
PH12017501527A1 (en) Oral hemostatic and wound-protective film
WO2009102465A3 (en) Continuous cell programming devices
BRPI0418469A (pt) composição polimérica biodegradável, pelìcula ou revestimento, artigo formado ou moldado, e métodos para produzir um artigo e uma composição polimérica biodegradável
WO2008122966A3 (en) A pharmaceutical composition of tacrolimus
AR054114A1 (es) Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
JP2013500072A5 (es)
WO2006071813A3 (en) Disposable medical supplies from hydrolytically biodegradable plastics
BR112014009065A2 (pt) polímeros de arquitetura controlada
BRPI1012051A2 (pt) "composição para o cuidado oral, filme de matriz polimétrica, e métodos para preparar o filme, e para tratar uma doença ou condição da cavidade oral"
WO2009131829A3 (en) Bone cement composition and method
ATE417637T1 (de) Polymerisches arzneimittelfreisetzungssystem für medizinische geräte
BR112015027024A2 (pt) formulações de gel para liberação prolongada de compostos voláteis

Legal Events

Date Code Title Description
FB Suspension of granting procedure